Australia Targets Patients And Doctors In Biosimilar Awareness Initiative
This article was originally published in SRA
Executive Summary
The Australian government is seeking feedback on a biosimilar awareness initiative for health professionals and consumers that will benefit from Aus$20m ($14.5m) in funding over the 2015-2018 period1.